ClinVar Miner

Submissions for variant NM_000224.3(KRT18):c.689G>C (p.Ser230Thr)

gnomAD frequency: 0.00405  dbSNP: rs58472472
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000056439 SCV001119464 likely benign not provided 2019-12-31 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000056439 SCV004133389 likely benign not provided 2022-03-01 criteria provided, single submitter clinical testing KRT18: BP4, BS2
Epithelial Biology; Institute of Medical Biology, Singapore RCV000056439 SCV000087548 not provided not provided no assertion provided not provided
Department of Pathology and Laboratory Medicine, Sinai Health System RCV000056439 SCV001553927 uncertain significance not provided no assertion criteria provided clinical testing The KRT18 p.Ser230Thr variant was not identified in the literature nor was it identified in Cosmic, however it was identified in dbSNP (ID: rs58472472), ClinVar (clinical significance not provided) and LOVD 3.0. The variant was identified in control databases in 1028 of 282750 chromosomes (6 homozygous) at a frequency of 0.003636 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European (non-Finnish) in 785 of 129112 chromosomes (freq: 0.00608), Other in 25 of 7214 chromosomes (freq: 0.003465), Latino in 91 of 35440 chromosomes (freq: 0.002568), South Asian in 58 of 30616 chromosomes (freq: 0.001894), African in 33 of 24930 chromosomes (freq: 0.001324), European (Finnish) in 26 of 25120 chromosomes (freq: 0.001035) and Ashkenazi Jewish in 10 of 10370 chromosomes (freq: 0.000964); it was not observed in the East Asian population. This variant was identified in 2/329 German patients with chronic hepatitis C, 2/344 patients with acute liver failure and 4/97 patients with IBD (Strnad_2006_PMID: 16729313; Strnad_2010_PMID: 20538000; Owens_2004_PMID: 15090596). However it should be noted that the authors from these studies referred to this variant as a polymorphism rather than a mutation and did not suspect significant biological relevance. Further, functional in vitro studies of this variant in cell models suggested conflicting results regarding the potential pathogenicity of this variant (Owens_2004_PMID: 15090596; Zupancic_2014_PMID: 24915158). The p.Ser230 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.